Amphastar Pharmaceuticals... (AMPH)
NASDAQ: AMPH
· Real-Time Price · USD
29.87
-0.34 (-1.13%)
At close: Aug 15, 2025, 3:59 PM
29.83
-0.13%
After-hours: Aug 15, 2025, 07:19 PM EDT
Amphastar Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 187.69M | 182.78M | 151.61M | 192.12M | 189.62M | 201.15M | 144.53M | 266.78M | 148.59M | 176.62M | 156.1M | 157.24M | 166.16M | 172.63M | 126.35M | 106.61M | 105.43M | 101.6M |
Short-Term Investments | 44.06M | 54.1M | 70.04M | 58.38M | 28.16M | 88.41M | 112.51M | 33.1M | 14.54M | 16.28M | 19.66M | 26.84M | 17.23M | 14.38M | 10.32M | 8.02M | 11.74M | 13.53M |
Long-Term Investments | 2.05M | 5.91M | 11M | n/a | 9.94M | 15.16M | 15.21M | 2M | 1.46M | 1.76M | 2.41M | 2.69M | 3.06M | 3.32M | 3.98M | 4.19M | n/a | n/a |
Other Long-Term Assets | 28.1M | 22.99M | 25.99M | 23.66M | 24.26M | 23.37M | 25.91M | 25.3M | 20.27M | 18.54M | 20.86M | 20.55M | 18.68M | 16.3M | 16.66M | 11.61M | 9.44M | 7.21M |
Receivables | 132.98M | 145.39M | 138.04M | 144.98M | 132.08M | 138.9M | 114.94M | 118.99M | 104.72M | 100.64M | 88.8M | 77.1M | 80.81M | 73.17M | 78.8M | 78.09M | 67.89M | 77.94M |
Inventory | 191.73M | 185.48M | 153.74M | 130.32M | 122.41M | 115.49M | 105.83M | 109.98M | 104.62M | 103.65M | 103.58M | 103.25M | 98.73M | 95.15M | 92.81M | 100.24M | 97.93M | 97.11M |
Other Current Assets | 24.37M | 20.21M | 20.65M | 20.16M | 10.38M | 11.13M | 2.96M | 7.96M | 12.09M | 10.49M | 10.17M | 13.8M | 8.31M | 2.66M | 2.56M | 2.96M | 22.08M | 3.23M |
Total Current Assets | 580.83M | 587.96M | 534.07M | 545.95M | 482.64M | 555.08M | 489.6M | 543M | 384.55M | 407.67M | 378.32M | 384.22M | 377.14M | 364.42M | 318.12M | 303.67M | 310.97M | 300.16M |
Property-Plant & Equipment | 354.73M | 353.76M | 344.63M | 327.52M | 320.57M | 320.39M | 315.64M | 314.11M | 305.51M | 269.99M | 264.57M | 259.8M | 264.73M | 271.37M | 271.49M | 271.01M | 280.3M | 273.14M |
Goodwill & Intangibles | 578.5M | 584.53M | 590.66M | 594.8M | 600.85M | 607.06M | 613.29M | 619.35M | 625.6M | 37.18M | 37.3M | 37.04M | 37.7M | 38.44M | 38.87M | 39.19M | 40.05M | 40.24M |
Total Long-Term Assets | 1.03B | 1.04B | 1.04B | 999.23M | 1.01B | 1.02B | 1.02B | 1B | 993.71M | 365.99M | 363.67M | 342.47M | 346.57M | 351.82M | 353.41M | 348.01M | 354.77M | 345.57M |
Total Assets | 1.62B | 1.63B | 1.58B | 1.55B | 1.49B | 1.57B | 1.51B | 1.54B | 1.38B | 773.66M | 741.99M | 726.7M | 723.72M | 716.24M | 671.53M | 651.68M | 665.75M | 645.74M |
Account Payables | 41.88M | 52.81M | 30.51M | 34.09M | 31.77M | 36.53M | 25.44M | 31.97M | 18.83M | 21.98M | 20.5M | 19.96M | 31.07M | 23.84M | 22.21M | 21.66M | 27.75M | 22.99M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -217.54M | n/a | n/a | n/a | -69.91M | n/a | -67.33M | -67.25M | n/a | n/a |
Short-Term Debt | 8.81M | 224K | 234K | 252K | 249K | 428K | 436K | 433K | 16.05M | 5.16M | 3.05M | 4.86M | 5.37M | 5.44M | 2.2M | 5.12M | 11.31M | 15.88M |
Other Current Liabilities | 96.54M | n/a | 100.53M | n/a | n/a | n/a | n/a | n/a | 188.35M | 14.23M | 22.12M | 19.12M | 38.64M | 57.63M | n/a | 41.03M | 54.69M | 55.11M |
Total Current Liabilities | 176.41M | 199.05M | 173.76M | 159.01M | 136.97M | 255.17M | 225.41M | 257.96M | 251.28M | 105.64M | 94.86M | 102.19M | 103.63M | 114.36M | 103.81M | 97.99M | 124.55M | 127.1M |
Long-Term Debt | 38.96M | 603.86M | 601.4M | 596.45M | 586.85M | 594.01M | 589.2M | 638.21M | 488.28M | 72.87M | 72.84M | 74.01M | 73.87M | 74.35M | 74.62M | 75.55M | 30.46M | 31.82M |
Other Long-Term Liabilities | 642.48M | 31.38M | 27.9M | 33.1M | 24.87M | 24.05M | 28.78M | 22.92M | 24.86M | 22.4M | 21.79M | 20.72M | 21.86M | 22.02M | 22.18M | 19.59M | 18.19M | 18.65M |
Total Long-Term Liabilities | 681.44M | 675.94M | 671.41M | 658.49M | 641.21M | 646.79M | 648.08M | 691.53M | 537.75M | 119.44M | 118.47M | 119.34M | 120.78M | 122.35M | 122.2M | 123.51M | 73.97M | 67.68M |
Total Liabilities | 857.85M | 874.99M | 845.17M | 817.5M | 778.18M | 901.96M | 873.49M | 949.49M | 789.03M | 225.08M | 213.33M | 221.53M | 224.41M | 236.71M | 226.01M | 221.5M | 198.52M | 194.78M |
Total Debt | 47.77M | 652.53M | 650.55M | 629.85M | 620.58M | 627.12M | 623.64M | 672.56M | 528.74M | 102.03M | 102.58M | 103.24M | 103.92M | 105.28M | 104.66M | 106.14M | 66.33M | 64.67M |
Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K |
Retained Earnings | 625.1M | 594.07M | 568.79M | 530.82M | 490.39M | 452.44M | 409.27M | 373.1M | 323.88M | 297.75M | 271.72M | 237.81M | 221.94M | 204.59M | 180.34M | 160.58M | 130.58M | 122.81M |
Comprehensive Income | -5.36M | -7.97M | -9.18M | -8.82M | -8.83M | -8.77M | -8.48M | -8.41M | -8.32M | -8.27M | -8.62M | -9.93M | -8.71M | -7.25M | -6.76M | -6.28M | -4.93M | -5.64M |
Shareholders Equity | 757.48M | 751.28M | 732.3M | 727.68M | 713.35M | 672.36M | 639.42M | 595.14M | 589.24M | 548.58M | 528.66M | 505.17M | 499.31M | 479.52M | 445.52M | 430.18M | 421.99M | 405.56M |
Total Investments | 46.11M | 60.01M | 81.03M | 58.38M | 38.1M | 103.57M | 129.92M | 35.1M | 14.54M | 18.04M | 22.08M | 29.53M | 20.3M | 17.7M | 14.3M | 12.21M | 11.74M | 13.53M |